Developing first-in-class precision medicines for cancer and other serious diseases
Total raised: $177M
Investors 1
| Date | Name | Website |
| 26.06.2025 | Vida Ventu... | vidaventur... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 10.06.2025 | - | $177M | - |
Mentions in press and media 2
| Date | Title | Description |
| 11.06.2025 | Antares Therapeutics Raises $177M in Series A Funding | Antares Therapeutics, a Boston, MA-based biotechnology company developing precision medicines for cancer and other serious diseases, raised $177M in Series A funding. The round was led by Omega Funds, Atlas Venture, Lightspeed Venture Partn... |
| 10.06.2025 | Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases | - |